DKP
ACOR

Davidson Kempner Partners’s Acorda Therapeutics ACOR Stock Holding History

Davidson Kempner Partners’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$1.01M Buy
+90,154
New +$1.5M 0.02% 204

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Davidson Kempner Partners's ACOR Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Acorda Therapeutics (ACOR) in Q1 2023: 90,154 shares worth $1.01M. The stake represents 0.02% of the portfolio and ranks #204 among its holdings.

29 funds tracked by Wall St. Rank hold ACOR as of Q1 2023.

  • Davidson Kempner Partners held 90,154 shares of Acorda Therapeutics worth $1.01M as of Q1 2023.
  • Acorda Therapeutics was a new Davidson Kempner Partners position in Q1 2023.
  • Acorda Therapeutics made up 0.02% of Davidson Kempner Partners's portfolio in Q1 2023, its #204 holding.
  • 29 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.